Skip to main content
Back
ISRG logo

Intuitive Surgical, Inc.

Data quality: 100%
ISRG
NASDAQ Healthcare Medical - Instruments & Supplies
$478.04
▲ $0.07 (0.01%)
Mkt Cap: 169.77B
Day Range
$478.03 $489.00
52-Week Range
$425.00 $603.88
Volume
1,500,865
50D / 200D Avg
$505.85 / $509.44
Prev Close
$477.97

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (626 peers)

Metric Stock Sector Median
P/E 59.4 0.4
P/B 9.5 2.9
ROE % 16.7 3.7
Net Margin % 28.4 3.8
Rev Growth 5Y % 15.2 10.0
D/E 0.0 0.2

Insider Trading Activity

20 transactions
Date Insider Type Shares Price Value
Feb 28, 2026
Samath Jamie
EVP & CFO & Enterprise Technol
 other 28,766 — —
Jan 29, 2026
Leonard Keith R
Director
 other 369 — —
Dec 15, 2025
Brosius Mark
See Remarks
 sell 464 $548.49 $254,499
Dec 12, 2025
Brosius Mark
See Remarks
 sell 312 $547.36 $170,776
Dec 10, 2025
Curet Myriam
EVP & Chief Medical Officer
 other 208 $229.39 —
Dec 10, 2025
Curet Myriam
EVP & Chief Medical Officer
 sell 104 $559.90 $58,230
Nov 12, 2025
BARRATT CRAIG H
Director
 other 1,500 $71.32 —
Nov 12, 2025
BARRATT CRAIG H
Director
 sell 750 $580.00 $435,000
Nov 12, 2025
Leonard Keith R
Director
 other 1,606 — —
Sep 4, 2025
Ladd Amy L
Director
 sell 335 $440.69 $147,631
Sep 3, 2025
Ladd Amy L
Director
 sell 336 $470.11 $157,957
Jun 4, 2025
Rosa David J.
President
 other 851 — —
May 16, 2025
Brosius Mark
SVP & Chief Mfg and Supply Cha
 sell 20 $563.81 $11,276
May 15, 2025
Brosius Mark
SVP & Chief Mfg and Supply Cha
 sell 22 $560.00 $12,320
May 14, 2025
Brosius Mark
SVP & Chief Mfg and Supply Cha
 sell 22 $563.00 $12,386
May 13, 2025
Brosius Mark
SVP & Chief Mfg and Supply Cha
 sell 22 $561.67 $12,357
May 12, 2025
Brosius Mark
SVP & Chief Mfg and Supply Cha
 sell 22 $551.97 $12,143
May 1, 2025
Leonard Keith R
Director
 grant 531 — —
May 1, 2025
NACHTSHEIM JAMI K
Director
 other 4,800 $90.49 —
May 1, 2025
NACHTSHEIM JAMI K
Director
 sell 2,400 $520.00 $1,248,000

Key Takeaways

Revenue grew 15.22% annually over 5 years — strong growth
Earnings grew 22.97% over the past year
ROE of 16.67% — decent returns on equity
Net margin of 28.38% shows strong profitability
Debt/Equity of 0.02 — conservative balance sheet
Generating 2.49B in free cash flow

Growth

Revenue Growth (5Y)
15.22%
Revenue (1Y)20.51%
Earnings (1Y)22.97%
FCF Growth (3Y)82.28%

Quality

Return on Equity
16.67%
ROIC12.19%
Net Margin28.38%
Op. Margin29.27%

Safety

Debt / Equity
0.02
Current Ratio4.87
Interest Coverage0.00

Valuation

P/E Ratio
59.44
P/B Ratio9.52
EV/EBITDA56.60
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 20.51% Revenue Growth (3Y) 18.86%
Earnings Growth (1Y) 22.97% Earnings Growth (3Y) 26.03%
Revenue Growth (5Y) 15.22% Earnings Growth (5Y) 13.77%
Profitability
Revenue (TTM) 10.06B Net Income (TTM) 2.86B
ROE 16.67% ROA 13.84%
Gross Margin 66.00% Operating Margin 29.27%
Net Margin 28.38% Free Cash Flow (TTM) 2.49B
ROIC 12.19% FCF Growth (3Y) 82.28%
Safety
Debt / Equity 0.02 Current Ratio 4.87
Interest Coverage 0.00 Dividend Yield 0.00%
Valuation
P/E Ratio 59.44 P/B Ratio 9.52
P/S Ratio 16.87 PEG Ratio 3.17
EV/EBITDA 56.60 Dividend Yield 0.00%
Market Cap 169.77B Enterprise Value 166.70B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 10.06B 8.35B 7.12B 6.22B 5.71B
Net Income 2.86B 2.32B 1.80B 1.32B 1.70B
EPS (Diluted) 7.87 6.42 5.03 3.65 4.66
Gross Profit 6.64B 5.63B 4.73B 4.20B 3.96B
Operating Income 2.95B 2.35B 1.77B 1.58B 1.82B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 20.63B 18.84B 15.44B 12.97B 13.56B
Total Liabilities 2.69B 2.31B 2.04B 1.86B 1.60B
Shareholders' Equity 17.82B 16.43B 13.31B 11.04B 11.95B
Total Debt 302.80M 146.00M 0.0 0.0 87.00M
Cash & Equivalents 3.37B 2.03B 2.75B 1.58B 1.29B
Current Assets 9.78B 7.11B 7.89B 6.25B 5.84B
Current Liabilities 2.01B 1.75B 1.66B 1.42B 1.15B